Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.

[1]  S. Forman,et al.  Hematopoietic Cell Transplantation , 2015 .

[2]  H. Tamaki,et al.  Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT , 2012, Bone Marrow Transplantation.

[3]  T. Pruett.  Desensitization in HLA-Incompatible Kidney Recipients and Survival , 2012 .

[4]  J. Ritz,et al.  Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. , 2011, Blood.

[5]  P. Thall,et al.  Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. , 2011, Blood.

[6]  D. Focosi,et al.  The role of anti-HLA antibodies in hematopoietic stem cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  Mary S Leffell,et al.  The calculated panel reactive antibody policy: an advancement improving organ allocation , 2011, Current opinion in organ transplantation.

[8]  J. Wingard,et al.  Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. , 2011, Blood.

[9]  H. Azuma,et al.  The impact of anti-HLA antibodies on unrelated cord blood transplantations. , 2010, Blood.

[10]  A. Zachary,et al.  Barriers to successful transplantation of the sensitized patient , 2010, Expert review of clinical immunology.

[11]  C. Huff,et al.  Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  J. Klein,et al.  The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. , 2007, Blood.

[13]  Jeffrey T. Sholander,et al.  Using real data for a virtual crossmatch. , 2009, Human immunology.

[14]  A. Zachary,et al.  Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. , 2009, Human immunology.

[15]  E. Shpall,et al.  High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem Cell Transplantation , 2009 .

[16]  A. Zachary,et al.  Detecting and monitoring human leukocyte antigen-specific antibodies. , 2008, Human immunology.

[17]  W. Stock,et al.  Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  Allen R. Chen,et al.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  J. Serody,et al.  Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. , 2007, Blood.

[20]  R. Montgomery,et al.  Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. , 2005, Human immunology.

[21]  R. Montgomery,et al.  Transplanting patients with a positive donor‐specific crossmatch: A single center's perspective , 2004, Pediatric transplantation.

[22]  F. Appelbaum,et al.  Thomas' hematopoietic cell transplantation , 2003 .

[23]  R. Montgomery,et al.  Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients , 2003, Transplantation.

[24]  J. Wagner,et al.  HEMATOPOIETIC CELL TRANSPLANTATION : MARROW OR UMBILICAL CORD BLOOD ? , 2003 .

[25]  R. Iannone,et al.  Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. , 2001, Blood.

[26]  Richard J. Jones,et al.  ELIMINATION OF ALLOANTIBODIES BY IMMUNOABLATIVE HIGH-DOSE CYCLOPHOSPHAMIDE 1 , 2001, Transplantation.

[27]  R. Montgomery,et al.  PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS , 2000, Transplantation.

[28]  R. Bray,et al.  Sensitization and sensitivity: defining the unsensitized patient. , 2000, Transplantation.

[29]  K. Sullivan,et al.  Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. , 1989, The New England journal of medicine.